Delivery Order SPE2DB20D3101-SPE2DB23FRDZ7
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $7,575.65 to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of 4,557,396,824 units of Durolane 60 mg/3 ml syringes. The award, which has an ultimate completion date of June 2, 2022, is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $9,249.32 delivery order for the supply of the pharmaceutical product DUROLANE 60 MG/3 ML SYRINGE 3ML. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD), and has a completion date of May 23, 2023. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,593.95 delivery order contract is for the supply of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product, with a completion date of February 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,968.74 firm fixed-price delivery order is for the supply of 4562747096 ! DUROLANE 60 MG/3 ML SYRINGE 3ML, with a period of performance through November 8, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $10,594.53 firm fixed-price delivery order is for the medical product DUROLANE 60 MG/3 ML SYRINGE 3ML. The contract has an ultimate completion date of September 7, 2023. This award is not associated with a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,068.33 firm fixed-price delivery order is for the supply of 4,568,037,376 units of the 60 mg/3 mL DUROLANE syringe. The contract has an ultimate completion date of April 28, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,556,332,202 units of Durolane 60 mg/3 ml syringes. The $4,495.98 firm-fixed-price contract has a completion date of February 22, 2022 and was not set aside for any specific business type. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This contract award, valued at $6,666.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of DUROLANE 60 MG/3 ML SYRINGE 3ML. The contract has a completion date of March 31, 2022 and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,257.17 firm fixed price delivery order is for the supply of 4567522902 DUROLANE 60 MG/3 ML SYRINGE 3ML, with a performance period through March 11, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,248.11, is a delivery order for the supply of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product. The contract has a firm fixed price pricing type and a performance period extending to May 7, 2025. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FRDZ7Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $11,093.04 for the supply of Durolane 60 mg/3 ml syringes. The contract was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of March 3, 2023. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. This specific Delivery Order is part of that larger IDC contract. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.1k | 3/2/23 |